SV40-transformed human corneal keratoeytes: Optimisation of serum-free culture conditions

Altex

Volumn 26, Issue 1, 2009, Pages 33-39

  Manzer, Anna Katharina ^a   Lombardi Borgia, Simone ^a   Schäfer Körting, Monika ^a   Seeber, Judith ^a   Zorn Kruppa, Michaela ^b   Engelke, Maria ^b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b German Animal Welfare Federation   (Germany)

Author keywords

SMA; Collagen gel contraction; Myofibroblast differentiation; SV40 immortalised human keratocytes; TGF 1

Indexed keywords

CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CELL TYPE; CORNEA CELL; FIBROBLAST; HUMAN; PHENOTYPE; REVIEW; ANIMAL TESTING ALTERNATIVE; ARTICLE; CELL LINE; CORNEA; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; GENETIC TRANSFORMATION; METHODOLOGY; SIMIAN VIRUS 40;

COLLAGEN;

ANIMAL TESTING ALTERNATIVES; CELL CULTURE TECHNIQUES; CELL LINE; CELL PROLIFERATION; COLLAGEN; CORNEA; CULTURE MEDIA, SERUM-FREE; FIBROBLASTS; HUMANS; SIMIAN VIRUS 40; TRANSFORMATION, GENETIC;

EID: 66149086600     PISSN: 09467785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Assouline, M., Chew, S. J., Thompson, H. W. and Beuerman, R. (1992). Effect of growth factors on collagen lattice contraction by human keratocytes. Invest. Ophthalmol. Vis. Sci. 33, 1742-1755.
2. Barry-Lane, P. A., Wilson, S. E., Cavanagh, H. D. et al. (1997). Characterization of SV40-transfected cell strains from rabbit keratocytes. Cornea 16, 72-78. (Pubitemid 27009131)
3. Beales, M. P., Funderburgh, J. L., Jester, J. V. and Hassell, J. R. (1999). Proteoglycan synthesis by bovine keratocytes and corneal fibroblasts: maintenance of the keratocyte phenotype in culture. Invest. Ophthalmol. Vis. Sci. 40, 1658-1663.
4. Berryhill, B. L., Kader, R., Kane, B. et al. (2002). Partial restoration of the keratocyte phenotype to bovine keratocytes made fibroblastic by serum. Invest. Ophthalmol. Vis. Sci. 43, 3416-3421.
5. Borderie, V. M., Mourra, N. and Laroche, L. (1999). Influence of fetal calf serum, fibroblast growth factors, and hepatocyte growth factor on three-dimensional cultures of human keratocytes in collagen gel matrix. Graefes Arch. Clin. Exp. Ophthalmol. 237, 861-869.
6. Engelke, M., Patzke, J., Tykhonova, S. et al. (2004). Assessment of ocular irritation by image processed quantification of cell injury in human corneal cell cultures and in corneal constructs. ATLA 32, 345-353. (Pubitemid 40139210)
7. Fini, M. E. (1999). Keratocyte and fibroblast phenotypes in the repairing cornea. Prog. Retin. Eye. Res. 18, 529-551.
8. Fini, M. E. and Stramer, B. M. (2005). How the cornea heals: cornea-specific repair mechanisms affecting surgical outcomes. Cornea 24, 2-11.
9. Funderburgh, J. L., Funderburgh, M. L., Mann, M. M. et al. (2001). Proteoglycan expression during transforming growth factor beta -induced keratocyte-myofibroblast transdifferentiation. J. Biol. Chem. 276, 44173-44178.
10. Hoffschir, F., Ricoul, M., Lemieux, N. et al. (1992). Jumping translocations originate clonal rearrangements in SV40-transformed human fibroblasts. Int. J. Cancer. 52, 130-136.
11. Jester, J. V., Petroll, W. M., Barry, P. A. and Cavanagh, H. D. (1995). Expression of alpha-smooth muscle (alpha-SM) actin during corneal stromal wound healing. Invest. Ophthalmol. Vis. Sci. 36, 809-819.
12. Jester, J. V., Barry-Lane, P. A., Cavanagh, H. D. and Petroll, W. M. (1996). Induction of alpha-smooth muscle actin expression and myofibroblast transformation in cultured corneal keratocytes. Cornea. 15, 505-516.
13. Jester, J. V., Huang, J., Barry-Lane, P. A. et al. (1999). Transforming growth factor(beta)-mediated corneal myofibroblast differentiation requires actin and fibronectin assembly. Invest. Ophthalmol. Vis. Sci. 40, 1959-1967.
14. Jester, J. V., Jiying, H., Molai, A. and Maurer, J. K. (2001). Extent of initial corneal injury as a basis for alternative eye ir- ritation tests. Toxicol. in Vitro 15, 115-130.
15. Jester, J. V. and Ho-Chang, J. (2003). Modulation of cultured corneal keratocyte phenotype by growth factors/cytokines control in vitro contractility and extracellular matrix contraction. Exp. Eye. Res. 77, 581-592.
16. Jester, J. V., Huang, J., Fisher, S. et al. (2003). Myofibroblast differentiation of normal human keratocytes and hTERT, extended-life human corneal fibroblasts. Invest. Ophthalmol. Vis. Sci. 44, 1850-1858.
17. Jester, J. V. (2006). Extent of corneal injury as a biomarker for hazard assessment and the development of alternative models to the Draize rabbit eye test. Cutan Ocul. Toxicol. 25, 41-54.
18. Kawakita, T., Espana, E. M., He, H. et al. (2006). Preservation and expansion of the primate keratocyte phenotype by down-regulating TGF-beta signaling in a low-calcium, serum-free medium. Invest. Ophthalmol. Vis. Sci. 47, 1918-1927.
19. Kurosaka, H., Kurosaka, D., Kato, K. et al. (1998). Transforming growth factor-beta 1 promotes contraction of collagen gel by bovine corneal fibroblasts through differentiation of myofibroblasts. Invest. Ophthalmol. Vis. Sci. 39, 699-704.
20. Maltseva, O., Folger, P., Zekaria, D. et al. (2001). Fibroblast growth factor reversal of the corneal myofibroblast phenotype. Invest. Ophthalmol. Vis. Sci. 42, 2490-2495.
21. Masui, T., Wakefield, L. M., Lechner, J. F. et al. (1986). Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 83, 2438-2442.
22. Masur, S. K., Dewal, H. S., Dinh, T. T. et al. (1996). Myofibroblasts differentiate from fibroblasts when plated at low density. Proc. Natl. Acad. Sci. U. S. A. 93, 4219-4223.
23. Maurer, J. K., Molai, A., Parker, R. D. et al. (2001). Pathology of ocular irritation with bleaching agents in the rabbit low-volume eye test. Toxicol. Pathol. 29, 308-319.
24. Maurer, J. K., Parker, R. D. and Jester, J. V. (2002). Extent of initial corneal injury as the mechanistic basis for ocular irritation: key findings and recommendations for the development of alternative assays. Regul. Toxicol. Pharmacol. 36, 106-117.
25. Mossman, T. (1983). Rapid colorimetric assay for cell growth and survival-application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
26. Petridou, S., Maltseva, O., Spanakis, S. and Masur, S. K. (2000). TGF-beta receptor expression and smad2 localization are cell density dependent in fibroblasts. Invest. Ophthalmol. Vis. Sci. 47, 89-95.
27. Wilson, S. E., Lloyd, S. A., He, Y. G. and Mccash, C. S. (1993). Extended life of human corneal endothelial cells transfected with the SV40 large T antigen. Invest. Ophthalmol. Vis. Sci. 34, 2112-2123.
28. Wilson, S. E., Weng, J., Blair, S. et al. (1995). Expression of E6/E7 or SV40 large T antigen-coding oncogenes in human corneal endothelial cells indicates regulated high-proliferative capacity. Invest. Ophthalmol. Vis. Sci. 36, 32-40.
29. Zorn-Kruppa, M., Tykhonova, S., Belge G. et al. (2004). Comparison of human corneal cell cultures in cytotoxicity testing. ALTEX 21, 129-134. (Pubitemid 39302790)
30. Zorn-Kruppa, M., Tykhonova, S., Belge, G. et al. (2005). A human corneal equivalent constructed from SV40-immortalised corneal cell lines. ATLA 33, 37-45. (Pubitemid 40476881)